17β-estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3

Irish Journal of Medical Science

Volumn 180, Issue 1, 2011, Pages 221-227

  Mu, P ^a   Tan, Z ^b   Cui, Y ^b   Liu, H ^b   Xu, X ^b   Huang, Q ^b   Zeng, L ^a   Wang, T ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

methyl cyclodextrin; 17 estradiol; Caveolin 3; Glucose intolerance; Insulin resistance; Tamoxifen

Indexed keywords

CAVEOLIN 3; ESTRADIOL; GLUCOSE; INSULIN; METHYL BETA CYCLODEXTRIN; PLACEBO; TAMOXIFEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIET; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MUSCLE CELL; NEWBORN; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SKELETAL MUSCLE;

ANIMALS; BETA-CYCLODEXTRINS; BLOTTING, WESTERN; CAVEOLIN 3; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HOMEOSTASIS; INSULIN RESISTANCE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; TAMOXIFEN; UP-REGULATION;

EID: 79954449295     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-010-0594-z     Document Type: Article

References (26)

1. Louet JF, LeMay C, Mauvais-Jarvis F (2004) Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6(3):180-185 (Pubitemid 38898916)
2. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116(7):1793-1801 (Pubitemid 44033299)
3. Nuutila P, Knuuti MJ, Maki M et al (1995) Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44(1):31-36
4. Donahue RP, Bean JA, Donahue RA, Goldberg RB, Prineas RJ (1997) Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study. Diabetes Care 20(11):1670-1676
5. Kanaya AM, Herrington D, Vittinghoff E et al (2003) Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. A randomized, doubleblind, placebo-controlled trial. Ann Intern Med 138(1):1-9 (Pubitemid 36232088)
6. Margolis KL, Bonds DE, Rodabough RJ et al (2004) Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47(7):1175-1187 (Pubitemid 39093314)
7. Cohen AW, Combs TP, Scherer PE, Lisanti MP (2003) Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 285 (6):E1151-E1160 (Pubitemid 37464364)
8. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER (2002) ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16(1):100-115 (Pubitemid 34044501)
9. Turi A, Kiss AL, Müllner N (2001) Estrogen downregulates the number of caveolae and the level of caveolin in uterine smooth muscle. Cell Biol Int 25(8):785-794 (Pubitemid 32744566)
10. Liu HM, Zhao XF, Guo LN, Tan Z, Wang TH (2007) Effects of caveolin-1 on the 17beta-estradiol-mediated inhibition of VSMC proliferation induced by vascular injury. Life Sci 80(8):800-812 (Pubitemid 46107997)
11. Gustavsson J, Parpal S, Karlsson M et al (1999) Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13(14):1961-1971 (Pubitemid 29517626)
12. Chen J, Capozza F, Wu A et al (2008) Regulation of insulin receptor substrate-1 expression levels by caveolin-1. J Cell Physiol 217(1):281-289
13. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF (1994) Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 127(5):1233-1243 (Pubitemid 24362559)
14. Cohen AW, Razani B, Wang XB et al (2003) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285 (1):C222-C235 (Pubitemid 36736354)
15. Capozza F, Combs TP, Cohen AW et al (2005) Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 288 (6):C1317-C1331 (Pubitemid 40991069)
16. Oshikawa J, Otsu K, Toya Y et al (2004) Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci USA 101(34):12670-12675 (Pubitemid 39122081)
17. Oh YS, Khil LY, Cho KA (2008) A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageingdependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia 51(6):1025-1034
18. Inokuchi J (2007) Insulin resistance as a membrane microdomain disorder. Yakugaku Zasshi 127(4):579-586 (Pubitemid 46536531)
19. Barros RP, Machado UF, Warner M, Gustafsson JA (2006) Muscle GLUT4 regulation by estrogen receptors ERa and ERb. Proc Natl Acad Sci USA 103(5):1605-1608 (Pubitemid 43192077)
20. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30(12):1000-1007
21. Sanger JW, Kang S, Siebrands CC et al (2005) How to build a myofibril. J Muscle Res Cell Motil 26 (6-8): 343-354
22. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Method 119(2):203-210 (Pubitemid 19132276)
23. Song D, Arikawa E, Galipeau DM et al (2005) Chronic estrogen treatment modifies insulin-induced insulin resistance and hypertension in ovariectomized rats. Am J Hypertens 18 (9 Pt 1):1189-1194 (Pubitemid 41337971)
24. Gao H, Bryzgalova G, Hedman E et al (2006) Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol 20(6):1287-1299 (Pubitemid 43801232)
25. Bryzgalova G, Lundholm L, Portwood N et al (2008) Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab 295 (4):E904-E912
26. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA (1993) A possible bimodel effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 60(4):664-667 (Pubitemid 23298511)